Physician profile
Holly Keyt
NPI 1699902965
$14,136.52
in general payments reported to CMS, 2019-2025
15 companies · $358 in 2025
The $358 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $2,523 · 2021: $346 · 2022: $63.26 · 2023: $21.52 · 2024: $183 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $12,889.72 | 2019-2025 | Arikayce |
| Vertex Pharmaceuticals Incorporated | $262.62 | 2019-2024 | |
| Gilead Sciences, INC. | $223.49 | 2019-2021 | |
| Chiesi USA, INC. | $150.68 | 2019-2021 | |
| Astellas Pharma US INC | $145.40 | 2024-2025 | Cresemba |
| Olympus America INC. | $134.52 | 2021 | |
| Abbvie INC. | $129.84 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $70.36 | 2025 | Livtencity, Glassia |
| Sanofi-Aventis U.S. LLC | $31.27 | 2025 | |
| Atricure, INC. | $23.77 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Advanced Respiratory, INC | $23.47 | 2020 | |
| Baxter Healthcare | $21.52 | 2023 | Hillrom - Life 2000 Ventilation System |
| Philips North America LLC | $15.41 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.45 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Keyt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.